11C-JMJ-129

N/A

Report date: 2025/11/21 17:16:25

NME

Base Information

Drug Name11C-JMJ-129

Drug Alias Name11C-JMJ-129

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11C +[4]

Mechanisms of ActionPositron-emission tomography enhancerscAMP-specific 3',5'-cyclic phosphodiesterase 4D inhibitors

TargetscAMP-specific 3',5'-cyclic phosphodiesterase 4D

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Mental Health (Nimh)

China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Mental Health (Nimh)

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A